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Abstract We have reached a conundrum in assigning
cause of death for sudden unexpected infant deaths. We
summarize the discordant perspectives and approaches and
how they have occurred, and recommend a pathway toward
improved consistency. This lack of consistency affects
pediatricians and other health care professionals, scientific
investigators, medical examiners and coroners, law
enforcement agencies, families, and support or advocacy
groups. We recommend that an interdisciplinary interna-
tional committee be organized to review current approa-
ches for assigning cause of death, and to identify a
consensus strategy for improving consistency. This effort
will need to encompass intrinsic risk factors or infant
vulnerability in addition to known environmental risk
factors including unsafe sleep settings, and must be suffi-
ciently flexible to accommodate a progressively expanding
knowledge base.
Keywords Sudden unexpected infant death  Sudden
infant death syndrome  Infant mortality
History of the term SIDS
Sudden infant death syndrome (SIDS) was originally
defined in 1969 [1], focusing attention on sudden death in
infants without an identified cause. These infants had a
similar age at death and a strong association with sleep in
common. Naming the sudden death SIDS instead of calling
it ‘‘cause unknown’’ facilitated an enhanced focus on
parental support and on research. Later studies identified
prone sleep as a significant risk factor for SIDS-classified
deaths [2–4]. The definition of SIDS was expanded in
1991, with an emphasis on scene investigation [5].
Although further modifications have been recommended
[6–9], no consensus has been achieved. Indeed, a review of
recent publications reported that the 1969 definition con-
tinues to be used 7 % of the time, the 1991 definition 35 %
of the time, other modifications 26 % of the time and in
20 % no definition was mentioned [10].
Initially there were no candidate etiologies to explain
these deaths. In the intervening years, however, much has
been learned about environmental, biological, and genetic
risk factors for deaths classified as SIDS. Once prone sleep
was identified as a significant risk factor, most developed
countries implemented back-to-sleep campaigns [11].
SIDS-classified death rates started to decline after 1990, as
did non-SIDS-classified postneonatal mortality rates, and
continued to decline until 2001 [11]. Much of this decline
was initially attributed to an overall decrease in SIDS-
classified deaths. Since 2001, however, SIDS-classified
death rates have not continued to decrease whereas there
has been a diagnostic shift to other assigned causes of
sudden unexpected infant death or to unknown cause.
Illustrating the impact of how these deaths are classified,
SIDS-classified deaths declined by 20 % from 2005 to
2011, whereas for the same period the rate of accidental
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infant deaths increased by 5 % and rates for undetermined/
unclassified deaths also increased [12, 13].
The dilemma
With improvements in death scene investigations, includ-
ing doll reenactment, medical examiners have been
increasingly reluctant to assign SIDS (ICD-10 Code R95)
as the cause of death. Adding to their reluctance was the
epidemiologic identification of modifiable risk factors such
as maternal cigarette smoking, bed-sharing, and soft bed-
ding. One viewpoint is that since ‘‘SIDS’’ is by definition a
diagnosis by exclusion, it should not be assigned as the
cause of death if a risk factor consistent with possible
asphyxia is present. In such instances, the cause assigned
may be accidental suffocation or strangulation in bed
(ASSB; ICD-10 Code W75) [11, 12]. Another viewpoint is
that ‘‘SIDS’’ should not be assigned as the cause of death
because every death must have a cause and if the post-
mortem investigation has not yielded one, it should be
classified as ‘‘unknown’’ (ICD-10 Code R99). This is
consistent with the approach to investigating and assigning
cause of death in older children and adults. Some medical
examiners object to the use of the term ‘‘syndrome’’ since
there is no pattern of medical findings present at routine
autopsy. In other cases, there may be a minor abnormality
found at autopsy such as occasional foci of bronchopneu-
monia or limited residual findings related to bronchopul-
monary dysplasia, and the death classified as having
resulted from that finding. Finally, others are unwilling to
assign the cause as SIDS unless all components of the
definition have been satisfied, including an adequate death
scene investigation.
Many deaths currently being classified as accidental suf-
focation are the same deaths classified as SIDS in past dec-
ades [14]. Studies of SIDS-classified deaths have identified
environmental factors that are potentially asphyxiating as
important risk factors, and there is thus an understandable
overlap of many of the risk factors for deaths classified as
SIDS and as ASSB [2, 3]. In reality, however, in many cases
when such risk factors are present, there is no clear physical
evidence of fatal airway compromise.Moreover, there are no
objective criteria for fatal suffocation unless the scene
investigation indicates obvious wedging or strangulation
such that an underlying vulnerability would have been
unnecessary to cause death. Otherwise, the conclusion that
the death is caused by a lethal asphyxiating environment is
based on circumstantial evidence of variable degrees of
certainty. The key question is whether or when an unsafe
sleep environment would be sufficient by itself to cause fatal
asphyxia in the absence of an underlying vulnerability.
Would most infants in the same environment have died?
More recently, the terms ‘‘SUID’’ and ‘‘SUDI’’ have
been introduced to encompass all sudden unexpected infant
deaths or sudden unexpected deaths in infancy, including
those that are both explained and unexplained. Sudden
unexpected deaths that remain unexplained after complete
postmortem evaluation are considered by many to be
equivalent to deaths previously classified as SIDS. Cur-
rently, there is no ICD-10 Code for ‘‘SUID’’ and any death
with the descriptors ‘‘SUID’’ or ‘‘SUDI’’ is assigned the
ICD-10 Code R95 for SIDS [13, 15]. The term ‘‘SUID’’
becomes further confused when some medical examiners
use it to refer to infant deaths where no cause of death is
found (i.e., unexplained instead of unexpected).
Interactions between infant vulnerability and unsafe
sleep environment
A common scientific explanation of ‘‘SIDS,’’ embodied in
the triple risk model introduced by Filiano and Kinney in
1994 [16], is that it results from an interaction between
infant vulnerability, a critical stage of development, and
some exogenous ‘‘trigger’’ or stressor. Exogenous sleep-
related stressors include prone position, over-bundling, bed
sharing, and soft bedding, which are either singly, or in
combination, potentially asphyxiating. The concept of a
critical maturational or developmental period is derived
from the peak incidence of these deaths in early infancy [2,
3]. The concept of vulnerability encompasses any intrinsic
condition that might impair an infant’s ability to respond to
significant environmental and/or positional asphyxia
encountered during sleep.
The importance of the relationship between infant vul-
nerability and environment is illustrated in the Fig. 1. In
this model, there are interactions between two continua: (1)
infant vulnerability and (2) a potentially asphyxiating sleep
environment. Importantly, interactions can occur anywhere
along the continua. Thus, a completely normal infant could
die in a severely asphyxiating environment and an extre-
mely vulnerable infant could die in a completely non-
asphyxiating environment. Most deaths, however, occur
between these two extremes.
A major advance in understanding the pathophysiology
of SIDS-classified deaths was the discovery, using auto-
radiographic and immuno-histochemical methods, that a
substantial subset of these infants has congenital, matura-
tional, or acquired brainstem dysfunction that likely con-
tributes to infant vulnerability [16, 17]. Importantly, these
deficiencies were present in up to 70 % of SIDS-classified
infants studied. These results have been confirmed in four
independent data sets and by investigators in Australia and
Japan [18, 19]. Kinney and colleagues have proposed that
dysfunction in brainstem serotonergic and GABAergic
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mechanisms that control or modulate heart rate, breathing,
body temperature, upper airway patency, sleep, and arou-
sal, impair an infant’s ability to respond to stressors often
encountered during sleep (Table 1) [17, 20–22]. These
‘‘protective’’ responses include arousal from sleep, car-
diorespiratory responses to hypoxia and/or hypercapnia,
motor responses required to lift and/or turn the head to
clear the airway, the laryngeal chemoreflex, and autore-
suscitation in response to asphyxia. Thus, infants with
brainstem dysfunction would be expected to have an
increased probability of death when faced with an adverse
or unsafe sleep environment (See Fig. 1).
A number of other ‘‘intrinsic’’ risk factors for SIDS-
classified deaths have also been identified that might affect
brainstem and autonomic function, including fetal exposure
to cigarette smoke, alcohol, cocaine, and other street drugs
[2–4]. Prematurity also significantly increases risk for
sudden unexpected death via unknown, but most likely
maturational, mechanisms. For example, the combination
of prematurity and bed-sharing has been found to
substantially increase the risk for SIDS-classified deaths
[23–25].
Francis Collins, Director of the NIH and past director of
the Human Genome Research Institute noted in a presen-
tation that ‘‘all illnesses have some hereditary contribution.
Genetics loads the gun and environment pulls the trigger.’’
In SIDS-classified deaths, genes regulating physiological
functions have been examined and summarized in recent
reviews [25, 26] (Table 2). Polymorphisms have been
related in particular to serotonin [26–31], cardiac chan-
nelopathies [32–34], and the autonomic nervous system
[25, 26] but have also been identified in genes regulating
inflammation and energy production [35–38]. Except for
the channelopathies, the precise mechanisms by which
these various polymorphisms might be a trigger for sudden
infant death are unclear. Other limitations of the genetic
studies include the limited power of some studies and lack
of confirmation of others [39]. Indeed, even the reported
serotonin gene variants may not have a significant role in
the pathogenesis of SIDS-classified deaths, based on a lack
Fig. 1 Schematic illustration of
the spectrum of variability in
risk for sudden unexpected
infant death and the spectrum of






Table 1 Brainstem abnormalities reported in SIDS-classified deaths
Decreased muscarinic (acetylcholine) and kainate (glutamate) receptor binding in the arcuate nucleus
Decreased LSD (serotonergic receptor) binding in the caudal raphe´, and other serotonergic regions
Decreased 5-HT1A receptor binding, increased numbers of (especially immature) 5-HT neurons, a relative decrease in SERT binding
Decreased levels of 5-HT and TPH2, the major synthesizing enzyme for 5-HT
Decreased GABAA receptor binding
5-HT 5-hydroxytryptamine (serotonin), 5-HT1A 5-HT receptor 1A, SERT serotonin transporter, TPH2 tryptophan hydroxylase 2, GABAA c-
aminobutyric acid receptor A
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of correlation with observed serotonin-related neuropa-
thologic brainstem abnormalities [39].
Summary and call to action
There is strong evidence confirming unsafe sleep envi-
ronment as a major risk factor for sleep-related sudden
unexpected infant deaths. Thus we need to continue to
expand and enhance our public health education efforts,
including more effectively overcoming persisting cultural,
historical, and other behavioral and socio-demographic
barriers to safe sleep for all infants. We must strengthen
our research efforts to identify underlying pathophysiology
and predictive markers that might further prevent these
tragic deaths. Unfortunately, however, the inconsistent
approach to assigning cause of death will persist until
consensus can be achieved among the various relevant
disciplines.
The reasons for the lack of broad-based acceptance of
any new approach to classification [7–9] are unclear and
likely multifactorial. At a minimum, however, contribu-
tions to this lack of consensus include the diversity in
international medical and legal approaches to assigning
cause of death, and failure to include all of relevant pro-
fessional and public disciplines in the discussion.
We recommend that an interdisciplinary international
committee be organized to review current approaches for
assigning final cause of death, and to identify a consensus
strategy for improving consistency. This effort may best be
Table 2 Categories of genes
for which the distribution of
polymorphisms differ in SIDS-
classified deaths compared to
controls
Except for the channelopathies,
the mechanisms by which these
polymorphisms lead to sudden
death are not known. Many
studies are of limited power,
and not all have been confirmed
Cardiac channelopathy polymorphisms
Potassium ion channel genes (KCNE2, KCNH2, KCNQ1)
Sodium ion channel gene (SCN5A) (long QT syndrome 3, Brugada syndrome)
GPD1-L (Brugada syndrome)
SCN3B (Brugada syndrome)
CAV3 (long QT syndrome 9)
SCN4B (long QT syndrome 10)
SNTA-1 (long QT syndrome 11)
RyR2 (catecholaminergic polymorphic ventricular tachycardia)
Serotonin polymorphisms (5-HT)
5-HT transporter protein (5-HTT)
Intron 2 of SLC6A4 [variable number tandem repeat (VNTR) polymorphism]
5-HT FEV gene
Autonomic nervous system polymorphisms
Paired-like homeobox 2a (PHOX2A)
PHOX2B
Rearranged during transfection factor (RET)
Endothelin converting enzyme-1 (ECE1)
T cell leukemia homeobox (TLX3)
Engrailed-1 (EN1)
Tyrosine hydroxylase (THO1)
Monamine oxidase A (MAOA)
Sodium/proton exchanger 3 (NHE3) (medullary respiratory control)
Infection and inflammation polymorphisms
Complement C4A
Complement C4B
Interleukin-1RN [gene encoding IL-1 receptor antagonist (ra); pro-inflammatory]
Interleukin-6 (IL-6) (pro-inflammatory)
Interleukin-8 (pro-inflammatory; associated with prone sleeping position)
Interleukin-10 (IL-10)
Vascular endothelial growth factor (VEGF) (pro-inflammatory)
Tumor necrosis factor (TNF)-a (pro-inflammatory)
Other categories of polymorphisms
Mitochondrial DNA (mtDNA) polymorphisms (energy production
Flavin-monooxygenase 3 (FMO3) (metabolizes nicotine; risk factor in mothers who smoke)
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coordinated by an international organization or individuals
without a vested interest in a particular outcome but having
the requisite credibility and consensus-building ability.
Since medical examiners and coroners have the difficult task
of classifying infant deaths, they need to have a prominent
role in this consensus process, as do the government agencies
responsible for tabulating vital statistics. Without a fully
participatory interdisciplinary international process, we will
not achieve the broad-based comprehensive endorsement
required for successful acceptance and implementation.
In summary, we need a more consistent approach to
assigning cause of death that is not only consistent with our
current understanding of environmental risks contributing
to an unsafe sleeping environment but also with interac-
tions with maturational and biologic vulnerability includ-
ing genetic risk factors. Rapidly evolving advances in
genetic technologies including next-generation sequencing
and other systems biologic approaches including meta-
bolomics should lead to progressive expansion of our
knowledge of relevant genetic and gene–environment
interactions and the identification of predictive markers
[40, 41]. We thus need an approach to classification that
not only addresses current inconsistencies but that is suf-
ficiently flexible to accommodate new knowledge
enhancing our understanding of the complex interactions
resulting in sleep-related sudden unexpected infant death.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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